# Pillar5 Pharma Inc., Arnprior, Canada – FDA Inspections

Source: https://www.keypedia.com/companies/pillar5-pharma-inc/8b94b834-f2da-4821-9ddc-6795a5e6d6f0

> Inspection records and compliance data for Pillar5 Pharma Inc. in Arnprior. 10 FDA inspections on record (1 OAI), 4 Form 483s, last inspected June 05, 2026.

---

## Details

- Name: Pillar5 Pharma Inc.
- FEI Number: 3000241849
- Canada Business Number: 837344662
- Address Line 1: 365 Madawaska Blvd,
- City: Arnprior
- Country Name: Canada
- Address: 365 Madawaska Blvd,, Arnprior, Canada
- Country: Canada

## Related Documents

- [483 - Pillar5 Pharma Inc. - 2026-06-05](https://www.keypedia.com/records/483/pillar5-pharma-inc/3c2f8832-59a1-4329-a5ef-379e2e12274d) — source: FDA, date: June 5, 2026
- [FDA Inspection 1323174 - Pillar5 Pharma Inc. - 2026-06-05](https://www.keypedia.com/records/fda_inspections/pillar5-pharma-inc/797a6a97-028e-475d-bd9f-5894cfb5abda) — source: FDA, date: June 5, 2026
- [Canada Inspection - Pillar5 Pharma Inc. - Inspection #87850 - 2025-12-02](https://www.keypedia.com/records/canada_inspection/pillar5-pharma-inc/6036db5f-3dcd-4ce5-95d2-0189f9f86208) — source: Canada, date: December 2, 2025
- Canada Inspection - Pillar5 Pharma Inc. - Inspection #87849 - 2025-12-02 — source: Canada, date: December 2, 2025
- [483 - Pillar5 Pharma Inc. - 2025-02-07](https://www.keypedia.com/records/483/pillar5-pharma-inc/aae128df-7323-4546-9ab7-cb02e0d26682) — source: FDA, date: February 7, 2025
- FDA Inspection 1261773 - Pillar5 Pharma Inc. - 2025-02-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2025
- [FDA Inspection 1261773 - Pillar5 Pharma Inc. - 2025-02-07](https://www.keypedia.com/records/fda_inspections/pillar5-pharma-inc/9bde498e-2566-4025-8c5b-53bacfb5ac30) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2025
- FDA Inspection 1261773 - Pillar5 Pharma Inc. - 2025-02-07 — source: FDA, date: February 7, 2025
- FDA Inspection 1261773 - Pillar5 Pharma Inc. - 2025-02-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2025
- Canada Inspection - Pillar5 Pharma Inc. - Inspection #82704 - 2024-01-29 — source: Canada, date: January 29, 2024
- Canada Inspection - Pillar5 Pharma Inc. - Inspection #82703 - 2024-01-29 — source: Canada, date: January 29, 2024
- [483 - Pillar5 Pharma Inc. - 2023-12-15](https://www.keypedia.com/records/483/pillar5-pharma-inc/49d12328-3ebf-4ca3-ade2-5b08703919fb) — source: FDA, date: December 15, 2023
- [FDA Inspection 1226692 - Pillar5 Pharma Inc. - 2023-12-15](https://www.keypedia.com/records/fda_inspections/pillar5-pharma-inc/d18f4f76-6e8e-4741-826d-9fbbd52772fb) — classification: Official Action Indicated (OAI), source: FDA, date: December 15, 2023
- FDA Inspection 1226692 - Pillar5 Pharma Inc. - 2023-12-15 — classification: No Action Indicated (NAI), source: FDA, date: December 15, 2023
- Canada Inspection - Pillar5 Pharma Inc. - Inspection #81067 - 2023-06-28 — source: Canada, date: June 28, 2023
- Canada Inspection - Pillar5 Pharma Inc. - Inspection #78409 - 2022-03-21 — source: Canada, date: March 21, 2022
- [483 - Pillar5 Pharma Inc. - 2020-02-21](https://www.keypedia.com/records/483/pillar5-pharma-inc/3fef87a0-f16d-4de4-bd43-7132bce6c38f) — source: FDA, date: February 21, 2020
- FDA Inspection 1119040 - Pillar5 Pharma Inc. - 2020-02-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 21, 2020
- FDA Inspection 1119040 - Pillar5 Pharma Inc. - 2020-02-21 — classification: No Action Indicated (NAI), source: FDA, date: February 21, 2020
- [Canada Inspection - Pillar5 Pharma Inc. - Inspection #72596 - 2019-10-30](https://www.keypedia.com/records/canada_inspection/pillar5-pharma-inc/ded5c606-5845-4668-80f2-965b85cb9bcd) — source: Canada, date: October 30, 2019

## Related Companies

- [Groupe Parima Inc.](https://www.keypedia.com/companies/groupe-parima-inc/49e213ea-3ec6-4535-adaf-c0b6c7d25a23)
- [Vetio Animal Health ULC](https://www.keypedia.com/companies/vetio-animal-health-ulc/7b019ca7-7830-408c-a1f0-bc4a533fd9a4)
- [Contract Pharmaceuticals Limited Canada](https://www.keypedia.com/companies/contract-pharmaceuticals-limited-canada/02ec2d1f-df8d-4636-95d2-b548aea571d8)
- [Viva Pharmaceutical Inc](https://www.keypedia.com/companies/viva-pharmaceutical-inc/0e5d1aa3-8369-4a0d-91b7-e516415fb219)
- [Cosmetica Laboratories Inc.](https://www.keypedia.com/companies/cosmetica-laboratories-inc/bcfa9f67-ec98-41ed-a67f-62ff5060c0be)
- [Labomar Canada Inc](https://www.keypedia.com/companies/labomar-canada-inc/1c212e6b-5d3d-4379-af67-cf8fde6c6aa4)
- [Delpharm Montreal Inc.](https://www.keypedia.com/companies/delpharm-montreal-inc/8d8c8dde-c584-4148-909c-c3c1db7c8268)
- [Cosmaceutical Research Lab Inc.](https://www.keypedia.com/companies/cosmaceutical-research-lab-inc/3713d087-c229-4b81-86b4-da71d519c6c0)
- [Kenvue Canada Inc.](https://www.keypedia.com/companies/kenvue-canada-inc/5ebdb680-6bdf-4d05-887c-3d175e32f038)
- [KDC/ONE Development Corporation, Inc.](https://www.keypedia.com/companies/kdcone-development-corporation-inc/3906f0b9-88a3-4c11-9833-e76f5df83b49)

## Related Officers

- [Investigator](https://www.keypedia.com/people/sarah-e-rhoades/d965990c-15cc-4722-b2d0-aea7206c71b0)
- [Drug Specialist  / Drug Investigator](https://www.keypedia.com/people/saundrea-a-munroe/129a869f-e1f2-4d59-b3ed-9613a9190f8a)
- [Investigator](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)
- [Miguel A. Martinez](https://www.keypedia.com/people/miguel-a-martinez/62e722b2-30bd-4671-9db9-8f089093e5a5)